ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,082Medicare Part D Prescriptions Filled, Including Refills

Rank: 405 out of 3001

$527K Total Retail Price of All Prescriptions

Rank: 582 out of 3001

643 Patients Receiving at Least One Drug in Part D
42%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

16% of this provider’s 643 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 4,882 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
SIMVASTATIN 554 302 1 1
AMLODIPINE BESYLATE 520 261 2 5
METFORMIN HCL 305 160 3 9
PROAIR HFA 267 88 4 30
LISINOPRIL 233 97 5 2
FUROSEMIDE 232 135 6 6
HYDROCODONE-ACETAMINOPHEN 210 63 S3 7 7
TRAMADOL HCL 206 105 8 17
OMEPRAZOLE 200 85 9 4
CLONIDINE HCL 199 92 10 64
LEVOTHYROXINE SODIUM 172 85 11 3
HYDROCHLOROTHIAZIDE 169 76 12 10
METOPROLOL TARTRATE 150 82 13 8
NEXIUM 148 64 14 23
GLIMEPIRIDE 137 103 15 31
CARVEDILOL 129 79 16 25
GABAPENTIN 126 40 17 14
CYCLOBENZAPRINE HCL 117 34 R 18 73
SPIRIVA 110 36 19 57
DICLOFENAC SODIUM 100 42 20 118
WARFARIN SODIUM 98 72 21 12
ATORVASTATIN CALCIUM 91 50 22 11
RANITIDINE HCL 89 25 23 41
AZITHROMYCIN 88 40 24 36
IBUPROFEN 84 12 25 74
LOSARTAN POTASSIUM 78 46 26 21
DIOVAN HCT 78 39 26 109
KLOR-CON M20 77 61 28 52
BENAZEPRIL HCL 74 39 29 123
CRESTOR 73 30 30 33
DIOVAN 69 64 31 50
LOSARTAN-HYDROCHLOROTHIAZIDE 68 54 32 49
TRIAMTERENE-HCTZ 68 26 32 48
MELOXICAM 67 42 34 34
PREDNISONE 66 31 35 39
METHOCARBAMOL 66 27 R 35 179
ZOLPIDEM TARTRATE 62 13 37 24
LANTUS 60 22 38 47
CYMBALTA 57 16 39 53
JANUVIA 56 34 40 54
CITALOPRAM HBR 53 0 41 16
TIZANIDINE HCL 51 13 42 101
LISINOPRIL-HYDROCHLOROTHIAZIDE 50 24 43 22
ALENDRONATE SODIUM 50 36 43 26
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 27, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.